Blue Horseshoe Stocks: Reviewing Big Runners

Gevo, Inc. GEVO

We threw GEVO into our extended watchlist on our website at BlueHorseshoeStocks.com yesterday morning, however, the tag did not make it into our email newsletters in time. Occasionally we will include last-minute ideas exclusive to the website, which is which we encourage our readers to check there each morning, even if they’ve already read our emails.

GEVO turned out to be the NASDAQ’s top traded stock of the day, posting an excellent single-session move from 4.42 to an impressive high of 21.00; a 375% rip.

This came on the heels of the EPA decision raising the amount of isobutanol in 16% gasoline blends, up from 12.5% This represents a significant margin of increase for the biofuel producer. With such a quick surge, we’ll also want to watch on the back end when the stock course corrects. There may also be a dip-and-rip opportunity on the horizon that we’ll be looking out for.


Canada Goose Holdings Inc. GOOS

We successfully tracked a host of GOOS weekly options calls on Friday morning, but today we wanted to return to comment on the solid move the stock itself has made since our alert.

From its low of 53.18 on Friday, GOOS has now made a very respectable two-session swing, reaching 63.30 yesterday. That’s a 25% increase, and for or a $50+ stock, a very nice two day performance.


Advanced Micro Devices, Inc. AMD

Speaking of great calls we’ve made on the stock side of things, we’ve been very successful with our coverage of AMD this spring. We initially tagged the stock in our watchlist on April 26th, and included a reminder on the 5th of this month, as the stock has posted a near-continual bull run in that time.

The day of our initial alert saw a low of 10.61 and never looked back, gradually leading to a new high of 17.34 yesterday. That works out to a rise of 64%


Extended Watchlist:
NEW, COTV, MYSZ, AMBO, RSLS

Blue Horseshoe Stocks: HOME Recap & More

Alibaba Group Holding Ltd. BABA – Options Idea

We’d like to start things off this morning by taking a look at BABA, which recently has formed a strong double-bottom setup on the chart. The stock is gapping up in premarket trading today, currently in the mid-$170’s and we’d like to formulate an extended term options idea to track over the next few weeks for an overdue recovery.

We’re going to zero in on the BABA 05/04 $180-187.50 Calls, which will give us plenty of time for the stock to realize the kind of gains that look very possible from a technical standpoint at this juncture.


At Home Group, Inc. HOME – Update

On the morning of March 23rd, we had selected a longer-term idea for the HOME options chain, and we wanted to take a look at the moves it has made in the three and a half weeks since that time.

Our target set of contracts was the HOME 04/20 $30 Calls, and with the stock surging to nearly $35 this week, those calls have been pushed well into the money and produced a heck of a gain opportunity. From the low shortly after our initial alert to a new high reach yesterday, we’ve seen a run from 1.31-5.50, which represents a chance at profits of up to 320%


Extended Watchlist:
ATRA, DQ, CHFS, RSLS, NVCN, HEAR

Blue Horseshoe Stocks: OREX Recap & More


Orexigen Therapeutics, Inc. OREX

On a day like yesterday, when the markets take an unexpected and brutal bath, it always helps to find a trend-bucker. Fortunately for us, all was not lost because we had included OREX on our watchlist in our premarket report.

Even as most other stocks wavered under the intensity of yesterdays bearish push, OREX ran from a daily low of .23 to a high of .39 for a 70% intraday run. It also closed with strength at .34, not too far below the area of a massive gap on the chart. We’ll definitely want to continue monitoring OREX, as even a partial filling of said gap would produce further gains of a significant magnitude.


_____

Bottom-Watch Plays

While we’re on the subject of bottom plays, we’re going to add both of the following to our working watchlist, as each one is extraordinarily oversold at the present time.

ReShape Life Sciences, Inc. RSLS
MoneyGram, International, Inc. MGI



Extended Watchlist:
AMPE, DFFN, CGEN, VATE, PLPL, CANB